US2020246440A1PendingUtilityA1

Dental pretreatment material and dental tissue regeneration kit

Assignee: NAT CT GERIATRICS & GERONTOLOGYPriority: Mar 31, 2016Filed: Apr 23, 2020Published: Aug 6, 2020
Est. expiryMar 31, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61L 2300/412A61L 2300/30A61L 2300/256A61L 2300/216A61L 27/54A61L 27/50A61L 27/3865A61L 27/3804A61L 27/3645A61L 27/3633A61K 6/56C07K 2317/76C07K 16/24A61K 2039/505A61K 6/69A61K 6/52A61P 1/02A61K 35/32A61K 35/28A61K 31/4439A61K 31/196A61L 2300/436A61L 2300/254A61L 27/3834A61K 6/00A61K 6/80A61K 38/48A61K 9/51C12Y 304/21004A61K 38/4826
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided is a dental pretreatment material for dental tissue regeneration by use of dental pulp stem cells, particularly a dental pretreatment material effectively enabling dental tissue regeneration even by use of dental pulp stem cells of middle-aged or older individuals. The dental pretreatment material is characterized by comprising a serine protease, specifically trypsin. The dental pretreatment material comprising trypsin is used as an injection into a root canal before a root canal filling material comprising dental pulp stem cells and an extracellular matrix is inserted into the root canal as an attempt to regenerate a dental pulp and a dentin. The root canal filling material includes an ALK5 inhibitor, a CCR3 antagonist, or a CCL11 neutralizing antibody.

Claims

exact text as granted — not AI-modified
1 . A dental pretreatment material for dental tissue regeneration, the dental pretreatment material comprising a serine protease. 
     
     
         2 . The dental pretreatment material of  claim 1 , wherein the serine protease is a chymotrypsin-like serine protease. 
     
     
         3 . The dental pretreatment material of  claim 2 , wherein the chymotrypsin-like serine protease is trypsin. 
     
     
         4 . The dental pretreatment material of  claim 1 , further comprising nano-bubbles. 
     
     
         5 . The dental pretreatment material of  claim 4 , wherein the nano-bubbles have a diameter ranging from 10 nm to 500 nm. 
     
     
         6 . The dental pretreatment material of  claim 1 , wherein the dental tissue regeneration is carried out by use of autologous or allogeneic dental pulp stem cells in an individual of middle or advanced age.

Join the waitlist — get patent alerts

Track US2020246440A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.